Biomimetic nanocarriers replicate natural biological components (e.g., cell membrane coatings, RBC-mimicking structures, platelet-inspired designs) to improve drug stability, targeted release, immune evasion, and site-specific delivery. They address limitations of traditional nanocarriers by enhancing biocompatibility and functionality. The market is driven by rising chronic disease burdens and...